XML 101 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Domestic and Foreign Components of Loss Before Income Taxes
The domestic and foreign components of loss before income taxes were as follows (in thousands):
Year Ended December 31,
202320222021
Domestic$(173,375)$(216,573)$(185,216)
Foreign(89,528)24,724 7,225 
Loss before income taxes$(262,903)$(191,849)$(177,991)
Schedule of Income Tax Expense (Benefit)
Income tax benefit for the year 2023 and the income tax expense for the years 2022 and 2021 consisted of the following (in thousands):
Year Ended December 31,
202320222021
Income tax expense:
Current:
Federal$— $— $— 
State— — — 
Foreign186 500 886 
Subtotal186 500 886 
Deferred:
Federal— — — 
State— — — 
Foreign(5,258)(71)(580)
Subtotal(5,258)(71)(580)
Income tax expense$(5,072)$429 $306 
Schedule of Difference Between Income Tax Expense (Benefit) and Federal Statutory Income Tax Rate to Loss Before Income Taxes
The difference between the income tax benefit for the year 2023 and the income tax expense for the years 2022 and 2021 and the amount computed by applying the federal statutory income tax rate to loss before income taxes is explained as follows (in thousands):
Year Ended December 31,
202320222021
Tax at federal statutory rate$(55,210)$(40,288)$(37,372)
State taxes, net(1,372)(6,895)(6,734)
Foreign rate differential(4,273)309 362 
Global Intangible Low-taxed Income791 1,002 637 
Non-deductible stock-based compensation4,770 3,545 2,770 
Research credits(7,020)(6,694)(5,230)
Change in valuation allowance49,016 44,005 45,373 
Transfer pricing settlement— 4,343 — 
Goodwill impairment9,764 — — 
Other(1,538)1,102 500 
Income tax expense$(5,072)$429 $306 
Schedule of Deferred Tax Assets and Liabilities and Based on Tax Jurisdictions Significant components of the Company’s deferred tax assets and liabilities are as follows (in thousands):
December 31,
20232022
Assets:
Deferred tax assets:
Net operating loss carryforwards$196,719 $174,129 
Research and development tax credit carryforwards54,336 44,264 
Stock-based compensation5,983 7,695 
Deferred revenue— 38,700 
Capitalized research71,675 37,985 
Fixed assets17,152 10,087 
Intangible assets101 — 
Lease liability8,559 10,074 
Accruals and reserves2,409 1,603 
Other259 283 
Total deferred tax asset357,193 324,820 
Valuation allowance351,430 301,840 
Deferred tax assets5,763 22,980 
Liabilities:
Intangible assets— (13,512)
Operating lease right-of-use assets(5,763)(14,620)
Deferred tax liabilities(5,763)(28,132)
Total net deferred tax liabilities$— $(5,152)
The deferred tax assets and liabilities based on tax jurisdictions are presented on the Consolidated Balance Sheets as follows (in thousands):
December 31,
20232022
Deferred tax assets (included in Other non-current assets on the Consolidated Balance Sheets)$— $1,118 
Deferred tax liabilities— (6,270)
Net deferred tax liabilities$— $(5,152)
Schedule of Unrecognized Tax Benefits
The following table summarizes the activity related to the Company’s unrecognized tax benefits (in thousands):
December 31,
202320222021
Beginning balance$18,179 $15,062 $12,892 
Additions based on tax positions related to the current year2,805 3,177 2,454 
Additions for tax positions of prior years29 278 130 
Reductions for tax positions of prior years(2,693)(338)(414)
Ending balance$18,320 $18,179 $15,062